Personal hearings working at the IHU revealed by “Mediapart” evoke PCR tests oriented to conclude in the efficacy of hydroxychloroquine.
by
It’s an additional crack in the fortress built by Professor Didier Raoult. A four days of the Board of Directors of the Hospital-University Institute (IHU) Mediterranean Infection, fixed at Tuesday, November 23, the Microbiologist Marseille, 69, is accused, according to the Mediapart website, of falsifications of scientific results by staff working within the IHU. A new revelation that follows that concerning clinical trials off authorization on the treatment of tuberculosis and further weakens the very controversial professor, at a time when the directors of the Institute he founded and directs, have an appointment for Study the process of its next replacement.
Confirmed in the world by sources within the University Hospitals of Marseille (AP-HM) and Aix-Marseille University (AMU), two of the IHU founding instances, the accusations to Didier Raoult have been formulated these Last weeks by members of the Institute, seconded by AMU, the AP-HM or the Institute for Research and Development (IRD), in individual hearings conducted as part of an internal investigation of the Hygiene Committee, Security and working conditions (CHSCT) from the university.
“Personality worship climate”
This diligent survey in the Emerging Virus Unit (UVE) laboratory, sheltered by the IHU, was desired by the President of AMU, Eric Berton. It gave rise to a prerequisite sent to all members of the Commission which led the hearings. Several laboratory employees denounce the “climate of personality worship” and “lack of contradictory debates” that reign inside the IHU. Recurring critic in Didier Raoult’s managerial methods.
More serious and unpublished, some of the auditioned staff report, according to Mediapart, having witnessed the falsification of biological results to conclude the beneficial effect of hydroxychloroquine, the flagship molecule of the care protocol advocated by the teacher Raoult since the beginning of the Pandemic of Covid-19 and no serious study could prove effectiveness. According to testimonies, the IHU would have analyzed differently from PCR tests in Marseille, on patients treated with hydroxycloroquine, and tests in Nice, on untreated persons with this molecule. An analysis on different criteria – 34 cycles for Patients Marseille, 39 for Niçois – “To make falsely conclude the efficiency of the molecule”. Joint by Le Monde Friday, November 19, the IHU did not wish to comment on these revelations.
You have 59.49% of this article to read. The rest is reserved for subscribers.